EMA Withdrawn: Apealea (paclitaxel) — Inceptua AB

View source ↗

Summary

EMA withdrawal of Apealea (paclitaxel) by Inceptua AB for ovarian neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Neoplasms

Drugs mentioned

• Apealea (paclitaxel)

Snippet

Status: Withdrawn. Therapeutic area: Ovarian Neoplasms. MAH: Inceptua AB. Decision date: 11/09/2023